Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.266
+0.024 (10.07%)
At close: Sep 27, 2024, 4:00 PM
0.265
-0.001 (-0.26%)
After-hours: Sep 27, 2024, 5:13 PM EDT
Lyra Therapeutics Stock Forecast
LYRA's stock price has decreased by -93.04% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Lyra Therapeutics stock have an average target of 4.50, with a low estimate of 0.50 and a high estimate of 11. The average target predicts an increase of 1,593.64% from the current stock price of 0.27.
Analyst Consensus: Buy
* Price targets were last updated on Aug 15, 2024.
Analyst Ratings
The average analyst rating for LYRA stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +652.73% | Aug 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $2 | Strong Buy → Hold | Downgrades | $2 | +652.73% | May 7, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $10 → $0.5 | Strong Buy → Hold | Downgrades | $10 → $0.5 | +88.18% | May 7, 2024 |
Financial Forecast
Revenue This Year
1.78M
from 1.56M
Increased by 13.99%
Revenue Next Year
717.88K
from 1.78M
Decreased by -59.58%
EPS This Year
-1.36
from -1.26
EPS Next Year
-0.76
from -1.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.4M | 1.7M | 19.8M | ||
| Avg | 1.8M | 717,876 | 8.1M | ||
| Low | 1.1M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 57.1% | -6.1% | 2,664.4% | ||
| Avg | 14.0% | -59.6% | 1,030.8% | ||
| Low | -30.8% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.16 | -0.39 | -0.29 | ||
| Avg | -1.36 | -0.76 | -0.71 | ||
| Low | -1.51 | -1.01 | -0.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.